Pfizer's Paxlovid, an oral antiviral COVID-19 treatment, was given full FDA approval on Thursday, paving the way for the drug's commercial sale after government supplies are exhausted. The treatment is approved for adults with COVID-19 who are at high risk for progression to severe infection.